Loading...

203 posters, 14 topics, 5 sessions, 817 authors, 256 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

The AAPS 102nd Annual Meeting

May 18-21, 2024 | The Westin Copley Place, Boston, MA

The AAPS 102nd Annual Meeting banner

D14

Traumatic Optic Neuropathy - Craniofacial Fracture Patterns And Management

Part of Topic

Craniofacial/Peds

Traumatic Optic Neuropathy – Craniofacial Fracture Patterns And Management

Nawal Shams,1 Bashar Hassan, MD,2,3 Ferris Zeitouni,3 Taylor Kolosky,1 Nicholas Randolph,1Magdi Elghannam,1 Shannath L. Merbs, MD, PhD,4 Paul N. Manson, MD,3 Michael P. Grant, MD, PhD2

1. University of Maryland School of Medicine, Baltimore, Maryland, USA, 2. Division of Plastic and Reconstructive Surgery, R Adams Cowley Shock Trauma Center, Baltimore, Maryland, USA,3. Department of Plastic and Reconstructive Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA, 4. Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA

Introduction

vUp to half of patients with traumatic optic neuropathy (TON) develop permanent vision loss.
vThe diagnosis and management of TON are challenging.
vPurpose: To identifycraniofacial fractures associated with TON and investigate the efficacy of steroid therapy in TON treatment.

Methods

vRetrospective cohort from 2018-2022 to determine craniofacial fractures associated with TON
vRetrospective cohort from2013-2022 to compare steroid therapy to oberservation
vTrauma patients with OFR at:
•R Adams Cowley Shock Trauma Center 
vPrimary outcome: visual acuity improvement andtime to improvement. 
vMultivariate logistic and linear regressions were performed

Results

Craniofacial Fracture Patterns

v2374 patients presented with acute faacial fractures between 2018-2022
v21 had TON (0.9%)
vSphenoid sinus fractures were associated with the greatest odds of TON (aOR [95% CI] 25 [9-68]) followed by LeFort III and naso-orbitoethmoid (NOE) fractures (aOR [95% CI] 13 [4-42] and 7 [2-24], respectively) 

TON Management

vBetween 2013 and 2022, treatment outcomes were analyzed in 86 TON patients (96 eyes).
v Median (IQR) follow up was 9 (4-31) months
vSteroid therapy consisted of  IV methylprednisolone ranging from 250-1000mg for 3 days max

 

vmore likely to have improvement in visual acuity with steroid therapy compared to those managed with observation (8/13 [62%], 27/83 [33%] , P<0.05)
vsteroids were associated with 6 times the odds of visual acuity improvement (aOR [95% CI] 5.54 [1.15-26.71], P=0.033)
v57-day quicker visual acuity improvement compared to observation (B=-57.1, P=0.007) 

Conclusion

vPatients with sphenoid sinus fractures should be evaluated for TON to initiate therapy early
Steroid therapy results in a more rapid improvement and better final visual acuity in management of TON







 
The AAPS 102nd Annual Meeting » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.